AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 18(2), 1969, pp. 253-257
Copyright © 1969 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, A. R.
Right arrow Articles by Mosley, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, A. R.
Right arrow Articles by Mosley, W. H.

Neutralization of the Vascular Permeability Factor of Vibrio Cholerae in Man

Albert R. Martin*, Thomas M. Vernon{dagger} AND Wiley H. Mosley
Epidemiology Section, Pakistan-SEATO Cholera Research Laboratory, {ddagger} Dacca, East Pakistan

The vascular permeability factor (PF) is one of the toxins derived from Vibrio cholerae that may play a role in the production of cholera diarrhea. A prospective study was performed among persons in an area endemic for cholera to determine if the ability to neutralize PF could be correlated with protection against cholera. Patients with cholera and their families were skin-tested with PF immediately after admission of the first patient to the hospital, and family members were followed for 10 days for bacteriologic evidence of infection and for symptoms of cholera. Results showed no evidence that ability to neutralize vascular PF could be associated with protection against V. cholerae infection or modification of the symptoms of the illness. In contrast, the vibriocidal antibody titer during the acute phase of infection did correlate well with resistance to cholera.


* Present address: Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114.


{dagger} Present address: U.S.A.I.D. Malaria Eradication Program, Kathmandu, Nepal.


{ddagger} The Pakistan-SEATO Cholera Research Laboratory is a part of the SEATO Cholera Research Program and is supported by the U. S. Agency for International Development, Department of State; the National Institutes of Health and the National Communicable Disease Center of the Department of Health, Education, and Welfare; and by the Governments of Pakistan, United Kingdom, and other SEATO nations. The NIH Cholera Advisory Committee coordinates the research program. These studies were supported in part by Research Agreement No. 196802 between the National Institutes of Health, Bethesda, Maryland, U.S.A., and the Pakistan-SEATO Cholera Research Laboratory, Dacca, East Pakistan.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by the American Society of Tropical Medicine and Hygiene.